Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
287 Leser
Artikel bewerten:
(1)

Juniper Advisory Adds Farley Reardon to its Health System M&A Advisory Group in Nashville

NASHVILLE, TN / ACCESSWIRE / November 2, 2023 / Juniper Advisory, a specialized investment banking firm focused exclusively on health system mergers and acquisitions, announced that Farley Reardon has joined the firm as a Managing Director in Nashville.

"I have worked with Juniper for over a decade and across the country on a range of strategic growth initiatives," said Mr. Reardon. "Juniper stands out as the most tenured team in the industry, advising full-time and continuously on change-of-control transactions. We believe that the forces afoot in the acute-care market will continue to create necessity for change and alignment, and that Juniper's expert advice will be increasingly important to management teams and boards evaluating partnerships."

Farley joins Juniper from Lifepoint Health in Nashville where he was Vice President of Strategic Growth & Development, primarily focused on acquisitions, divestitures and joint venture partnerships for acute care hospitals and related ancillary businesses. He has over 25 years of corporate development and capital markets experience. Prior to Lifepoint, he was in the institutional fixed income departments of Robert W. Baird & Co., Morgan Keegan & Co., J.C. Bradford & Co., and others. He holds an MBA from Vanderbilt University's Owen Graduate School of Management.

"Our team has developed a leading share of transformational hospital system combinations," said partner Rex Burgdorfer. "Farley's addition will perpetuate our trusted and rigorous approach to client service."

"Farley is talented and highly respected," noted partner Jordan Shields. His in-depth industry knowledge and relationships will enhance the level and breadth of our advisory services."

"Juniper's deep bench of senior bankers, who have dedicated their careers to not-for-profit mergers and acquisitions, lead the industry. We attribute our success in attracting these professionals and supporting their superior performance to our single product focus, allowing us to direct all of our attention to delivering excellent client service and achieving results that exceed our clients' expectations."

In addition to his work at Juniper, Farley is active with the Tennessee Chapter of JDRF both as a former board member and long-time supporter.

Select Juniper completed transaction in 2023 include Olathe Health - Kansas University Health System; Genesis Health - MercyOneTrinity; Mid-Columbia Medical Center - Adventist Health; Gerald Champion - CHRISTUS; Quorum Health - Java Medical Group; among others.

About Juniper Advisory

Juniper is a specialized, independent investment banking firm focused exclusively on providing hospitals, health systems, and higher education institutions with expert advice related to partnerships, affiliations, joint ventures, and a range of M&A strategies. Over the last 30 years, the Juniper team has worked with more than 250 of the nation's leading not-for-profit organizations on strategic business combinations and has advised on many of the most complex and innovative transactions in the hospital industry.

Additional information about Juniper Advisory can be found at www.juniperadvisory.com.

Contacts:

Juniper Advisory
Setina Hinojosa
Media Relations
110 North Wacker Drive, Suite 2500
Chicago, IL 60606
shinojosa@juniperadvisory.com
312.506.3000

SOURCE: Juniper Advisory

View source version on accesswire.com:
https://www.accesswire.com/798537/juniper-advisory-adds-farley-reardon-to-its-health-system-ma-advisory-group-in-nashville

© 2023 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.